Ubs Asset Management Americas Inc Keros Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 64,416 shares of KROS stock, worth $906,333. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,416
Previous 50,552
27.43%
Holding current value
$906,333
Previous $2.94 Million
65.28%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding KROS
# of Institutions
176Shares Held
31.1MCall Options Held
646KPut Options Held
670K-
Black Rock Inc. New York, NY2.51MShares$35.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.96MShares$27.5 Million0.0% of portfolio
-
Braidwell LP Stamford, CT1.89MShares$26.7 Million1.68% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.69MShares$23.7 Million2.53% of portfolio
-
State Street Corp Boston, MA1.2MShares$16.9 Million0.0% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $362M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...